Related Funds
Fund Name | Location |
Amtrust Ventures | New York, New York, United States |
Bank of Hangzhou | China, Hangzhou, Zhejiang |
BDC Healthcare Venture | Canada, Montréal, Quebec |
BHP | Australia, Melbourne, Victoria |
Brandify | Anaheim, California, United States |
Cristofoli Contracting | - |
Delphi | Berkeley, California, United States |
Dongchen Fund | - |
Dongqi Qiye | - |
NAV.VC | Reston, United States, Virginia |
NovEss | - |
Papillon ZAO | - |
Presidio Partners | California, San Francisco, United States |
Siam Cement Group | Bangkok, Krung Thep, Thailand |
Telecom Infra Project | California, Menlo Park, United States |
The Government Offices of Sweden | Stockholm, Stockholm County, Sweden |
The Provco Group | Bryn Mawr, Pennsylvania, United States |
Velar Capital | Austin, Texas, United States |
Walker & Dunlop | Bethesda, Maryland, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Scribe Therapeutics | $100M | 31 Mar 2021 | California, United States | ||
$95M | 12 Mar 2021 | Basel, Basel-City, Switzerland | |||
IO Biotech | $149M | 13 Jan 2021 | Capital Region of Denmark | ||
Olema Oncology | $85M | 01 Oct 2020 | San Francisco, California, United States | ||
Praxis Precision Medicines | $110M | 28 Jul 2020 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Scribe Therapeutics | $100M | 31 Mar 2021 | California, United States | ||
$95M | 12 Mar 2021 | Basel, Basel-City, Switzerland | |||
IO Biotech | $149M | 13 Jan 2021 | Capital Region of Denmark | ||
Olema Oncology | $85M | 01 Oct 2020 | San Francisco, California, United States | ||
Praxis Precision Medicines | $110M | 28 Jul 2020 | Cambridge, Massachusetts, United States |